EVENTOS ADVERSOS RELACIONADOS AO USO DA DIPIRONA NO BRASIL
EVENTOS ADVERSOS RELACIONADOS AO USO DA DIPIRONA NO BRASIL
-
DOI: https://doi.org/10.22533/at.ed.27124080717
-
Palavras-chave: Dipirona, Medicamentos, Farmacovigilância, VigMed
-
Keywords: Dipyrone, Medicines, Pharmacovigilance, VigMed
-
Abstract: The aim here is to provide an overview of the main reports of adverse events related to the use of dipyrone according to data available in the VigMed system in Brazil. Such data are available on the website: https://www.gov.br/anvisa/pt-br/acessoainformacao/dadosabertos/informacoes-analiticas/notificacoes-de-farmacovigilancia. From 2018 to April 2023, 2276 reports of adverse events related to the use of this medication were made. It is important to highlight that it is essential to know such data so that health managers, health professionals and public policy makers can take the necessary measures to reduce such events and provide greater safety for patients and individuals.
- Marcus Fernando da Silva Praxedes